Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Harvey I. Skulnick is active.

Publication


Featured researches published by Harvey I. Skulnick.


Carbohydrate Research | 1981

Stereochemical control as a function of protecting-group participation in 2-deoxy-D-erythro-pentofuranosyl nucleosides☆

Wendell Wierenga; Harvey I. Skulnick

Abstract Possible features controlling the anomeric ratios in the synthesis of the antiviral antibiotic dihydro-5-azathymidine have been examined. Replacement of the 3- and 5-(4-methylbenzoyl) protecting groups in 2-deoxy- D - erythro -pentofuranosyl chloride by benzyl groups led to changes in anomeric ratios in stannic chloride-mediated condensations with both 5-methyl-2,4-bis(trimethylsilyl)triazine and 2,4-bis(trimethylsilyl)thymine. Analysis of the results suggested that steric elements, and more importantly, participating factors, of both the 3- and 5-protecting groups affect the anomeric ratios.


Bioorganic & Medicinal Chemistry Letters | 1997

Synthesis and pharmacological evaluation of sulfone substituted HIV protease inhibitors

Theresa M. Schwartz; Gordon L. Bundy; Joseph Walter Strohbach; Suvit Thaisrivongs; Paul D. Johnson; Harvey I. Skulnick; Paul K. Tomich; Janet C. Lynn; Kong Teck Chong; Roger R. Hinshaw; Thomas J. Raub; Guy E. Padbury; Lisa N. Toth

Abstract The sulfonamide substituted pyranones ( 1 ) have recently been shown to be potent HIV protease inhibitors. We prepared a series of sulfone substituted analogs and compared their biological activities to those of the corresponding sulfonamide analogs. It was determined that although these compounds maintained activity as enzyme inhibitors, they showed somewhat diminished antiviral activity even though they may possess increased membrane permeability.


Journal of Medicinal Chemistry | 1998

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

Steve R. Turner; Joseph Walter Strohbach; Ruben Tommasi; Paul A. Aristoff; Paul D. Johnson; Harvey I. Skulnick; Lester A. Dolak; Eric P. Seest; Paul K. Tomich; Michael John Bohanon; Miao-Miao Horng; Janet C. Lynn; Chong Kt; Roger R. Hinshaw; Keith D. Watenpaugh; Musiri N. Janakiraman; Suvit Thaisrivongs


Journal of Medicinal Chemistry | 1996

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.

Suvit Thaisrivongs; Harvey I. Skulnick; Steven Ronald Turner; Joseph Walter Strohbach; Ruben A Tommasi; Paul D. Johnson; Paul A. Aristoff; T.M Judge; Ronald B. Gammill; Joel Morris; K.R Romines; R.A Chrusciel; Roger R. Hinshaw; Chong Kt; W.G Tarpley; S.M Poppe; D.E Slade; Janet C. Lynn; Miao-Miao Horng; Paul K. Tomich; Eric P. Seest; Lester A. Dolak; Howe Wj; G.M Howard; Keith D. Watenpaugh


Journal of Medicinal Chemistry | 1997

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

Harvey I. Skulnick; Paul D. Johnson; Paul A. Aristoff; Morris Jk; Lovasz Kd; Howe Wj; Keith D. Watenpaugh; M.N Janakiraman; D.J Anderson; R.J Reischer; T.M Schwartz; L.S Banitt; Paul K. Tomich; Janet C. Lynn; Miao-Miao Horng; Chong Kt; Roger R. Hinshaw; Lester A. Dolak; Eric P. Seest; Francis J. Schwende; Bob D. Rush; G.M Howard; L.N Toth; K.R Wilkinson; T.J Kakuk; C.W Johnson; S.L Cole; R.M Zaya; G.L Zipp; P.L Possert


Journal of Organic Chemistry | 1979

General, efficient, one-step synthesis of .beta.-keto esters

Wendell Wierenga; Harvey I. Skulnick


Journal of Medicinal Chemistry | 1980

5-Substituted 2-amino-6-phenyl-4(3H)-pyrimidinones. Antiviral- and interferon-inducing agents

Wendell Wierenga; Harvey I. Skulnick; Dale A. Stringfellow; Sheldon D. Weed; Harold E. Renis; Emerson E. Eidson


Journal of Medicinal Chemistry | 1995

Structure-Based Design of Sulfonamide-Substituted Non-Peptidic HIV Protease Inhibitors

Harvey I. Skulnick; Paul D. Johnson; Howe Wj; Paul K. Tomich; Chong Kt; Keith D. Watenpaugh; Musiri N. Janakiraman; Lester A. Dolak; McGrath Jp; Janet C. Lynn


Archive | 1993

7-HALO- AND 7β,8β-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Jackson B. Hester; Roy A. Johnson; Robert C. Kelly; Eldon G. Midy; Harvey I. Skulnick


Archive | 1993

Protein kinase inhibitors and related compounds combined with taxol

Irene Abraham; Paul Adrian Aristoff; Harvey I. Skulnick

Collaboration


Dive into the Harvey I. Skulnick's collaboration.

Researchain Logo
Decentralizing Knowledge